Achieve Safe & Targeted In Vivo Delivery of Payloads with Clarity in Regulations & Appropriate Models to Advance the Next Frontier of In Vivo Editing from Research to Clinic

July 9-11, 2024 | Boston, MA

Welcome to the 3rd In Vivo Cell Engineering & Gene Editing Summit!

The ONLY event focused on both cellular and genetic frontiers

As promising pre-clinical results continue to emerge, the shift from the ‘dream’ of in vivo cell engineering and gene editing is rapidly becoming a reality, with numerous companies pushing towards the clinic.

The 3rd In Vivo Cell Engineering & Gene Editing Summit is an exclusive platform offering the latest advances in preclinical development, IND-enabling studies, first clinical data readouts, and more, while also providing clarity on the full in vivo landscape.

This is your chance to unite with industry giants like Capstan Therapeutics, Editas Medicine, NanoCell Therapeutics, Carisma Therapeutics, Mustang Bio, iECURE, and many others, for exclusive access to groundbreaking discoveries and networking opportunities, propelling your pipelines to new heights!

"In vivo genetic medicines are the future, so having a forum for leaders in the field to explore ways to navigate development to meet the needs of patients is very exciting"
Nicolas Boyle, Chief Executive Officer, Abintus Bio

Key Highlights

3rd In Vivo Cell Engineering & Gene Editing Summit

Exploring data-driven case studies to outline decision making when selecting viral versus non-viral vectors 

3rd In Vivo Cell Engineering & Gene Editing Summit

Clarifying regulatory expectations for this novel therapeutic approach to map out the future of your pipeline

3rd In Vivo Cell Engineering & Gene Editing Summit

Benchmarking appropriate preclinical models to support translation to gain valuable data needed by regulatory bodies

3rd In Vivo Cell Engineering & Gene Editing Summit

Outlining the considerations when scaling up towards the clinic to equip you with the tools to tackle bottlenecks

3rd In Vivo Cell Engineering & Gene Editing Summit

Emphasizing target specificity and the mitigation of off-site toxicities to ensure safety is front of mind in development

 

Download the Full Agenda for More Information on:

        • 15+ In Vivo Expert Speakers
        • 2 Interactive Deep-Dive Workshops
        • 8+ Hours of Industry Networking
        • & Much More!

       

       

 

 

3rd In Vivo Cell Engineering & Gene Editing Summit - Full Agenda

World-Class Speaker Faculty Includes

"The In Vivo Cell Engineering & Gene Editing Summit is a tremendous opportunity to engage with leaders in the field and discuss the latest advances"
Colin Exline, Head of Gene Editing, Primera Therapeutics